Establishment of a L-02 cell model of hepatic steatosis

Jinjin YIN; Waijiao TANG; Lu ZENG; Benjie ZHOU.
Journal of Southern Medical University ; (12): 837-842, 2014.
Artículo en Zh | WPRIM | ID: wpr-249348

Documentos relacionados

  1. Discrepancy Between NAFLD and MAFLD: Is it Only Due to Misclassification of MAFLD?
  2. Editorial: "Lean" NAFLD: Metabolic Obesity with Normal BMI… Is It in the Genes?
  3. Altered lipid metabolism and the development of metabolic-associated fatty liver disease.
  4. Embracing Change: From Nonalcoholic Fatty Liver Disease to Metabolic Dysfunction-Associated Steatotic Liver Disease Under the Steatotic Liver Disease Umbrella.
  5. Paediatric steatotic liver disease has unique characteristics: A multisociety statement endorsing the new nomenclature.
  6. Positive association between proinsulin and fatty liver index in people with type 2 diabetes.
  7. [Clinical status and challenges of new drugs for metabolic dysfunction-associated fatty liver disease].
  8. Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
  9. Alcoholic and non-alcoholic steatohepatitis.
  10. Reply to: "From NAFLD to MASLD: Promise and pitfalls of a new definition'.